Cumulus Neuroscience announced nearly £1.2m in funding from Innovate UK's Small Business Research Initiative (SBRI) to support ongoing clinical validation of AccelADx, a “breakthrough” screening test for early detection of Alzheimer's dementia.
With an estimated 60 million people living with Alzheimer’s disease today, “Quicker, more accurate ways to diagnose dementia are greatly...